Who Generates More Revenue? Biogen Inc. or Xencor, Inc.

Biogen Inc. vs. Xencor, Inc.: A Revenue Showdown

In the competitive landscape of biotechnology, revenue generation is a key indicator of a company's market position and growth potential. Over the past decade, Biogen Inc. has consistently outperformed Xencor, Inc. in terms of revenue. From 2014 to 2023, Biogen's revenue peaked in 2019, reaching approximately $14.4 billion, while Xencor's highest revenue was around $275 million in 2021. This stark contrast highlights Biogen's dominance, with revenues often exceeding Xencor's by over 100 times.

Despite Xencor's impressive growth, particularly between 2019 and 2021, where revenue increased by over 75%, it remains a smaller player compared to Biogen. This data underscores the significant scale and market reach of Biogen, a leader in the biotech industry. As both companies continue to innovate, it will be interesting to see how these revenue trends evolve in the coming years.